Wealthfront’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $1.29M | Buy |
33,382
+1,564
| +5% | +$60.2K | 0.01% | 204 |
|
|
2018
Q2 | $1.04M | Buy |
31,818
+3,033
| +11% | +$99.1K | 0.01% | 243 |
|
|
2018
Q1 | $786K | Buy |
28,785
+2,083
| +8% | +$56.9K | 0.01% | 302 |
|
|
2017
Q4 | $662K | Sell |
26,702
-1,254
| -4% | -$31.1K | 0.01% | 298 |
|
|
2017
Q3 | $815K | Sell |
27,956
-700
| -2% | -$20.4K | 0.01% | 231 |
|
|
2017
Q2 | $794K | Buy |
28,656
+1,949
| +7% | +$54K | 0.01% | 185 |
|
|
2017
Q1 | $664K | Buy |
26,707
+2,979
| +13% | +$74.1K | 0.01% | 178 |
|
|
2016
Q4 | $513K | Buy |
23,728
+1,513
| +7% | +$32.7K | 0.01% | 196 |
|
|
2016
Q3 | $529K | Buy |
22,215
+1,484
| +7% | +$35.3K | 0.01% | 173 |
|
|
2016
Q2 | $484K | Buy |
20,731
+2,254
| +12% | +$52.6K | 0.01% | 176 |
|
|
2016
Q1 | $348K | Sell |
18,477
-3,117
| -14% | -$58.7K | 0.01% | 217 |
|
|
2015
Q4 | $398K | Buy |
21,594
+6,905
| +47% | +$127K | 0.01% | 172 |
|
|
2015
Q3 | $241K | Buy |
14,689
+3,975
| +37% | +$65.2K | 0.01% | 240 |
|
|
2015
Q2 | $190K | Buy |
10,714
+2,098
| +24% | +$37.2K | 0.01% | 275 |
|
|
2015
Q1 | $153K | Buy |
8,616
+2,289
| +36% | +$40.6K | 0.01% | 302 |
|
|
2014
Q4 | $84K | Buy |
6,327
+5,010
| +380% | +$66.5K | ﹤0.01% | 387 |
|
|
2014
Q3 | $16K | Sell |
1,317
-1,950
| -60% | -$23.7K | ﹤0.01% | 513 |
|
|
2014
Q2 | $43K | Buy |
3,267
+375
| +13% | +$4.94K | ﹤0.01% | 394 |
|
|
2014
Q1 | $39K | Buy |
+2,892
| New | +$39K | ﹤0.01% | 318 |
|